Digestive Disease Week 2023


  • Thumbnail for AGA New Microbiome Mechanisms and Therapies: Complement, Cancer, and Customized Probiotics
    Date
    May 6, 2023
    Society: AGA

    The gut microbiome is implicated in a wide range of physiological processes, and holds great, but unrealized, potential for disease treatment and prevention. In this session, rising investigators demonstrate novel biotherapeutic applications of gut microbes, and how the intestinal bacterial community interacts with an arm of the innate immune system. The talks span the topics of bioengineered probiotics, anti-tumor activities of gut microbes, and introduce the complement system in the gut as an effector of antimicrobial defense.

    Moderators

    Speaker Image for Eugene Chang
    University of Chicago
    Speaker Image for Phillip Tarr
    Washington Univ School of Medicine
  • Thumbnail for MICROBIOME INDUCED COMPLEMENT SYNTHESIZED IN THE GUT PROTECTS AGAINST ENTERIC INFECTIONS
    Date
    May 6, 2023
    Society: AGA

    The gut microbiome is implicated in a wide range of physiological processes, and holds great, but unrealized, potential for disease treatment and prevention. In this session, rising investigators demonstrate novel biotherapeutic applications of gut microbes, and how the intestinal bacterial community interacts with an arm of the innate immune system. The talks span the topics of bioengineered probiotics, anti-tumor activities of gut microbes, and introduce the complement system in the gut as an effector of antimicrobial defense.

    Presenter

  • Thumbnail for AGA Emerging Disparities and Opportunities in the Digital Age
    Date
    May 6, 2023
    Society: AGA

    The use of technology has expanded rapidly in clinical care and research in gastroenterology. Telehealth has improved access to care and transformed the ability to monitor patients from the safety of their own homes. Artificial intelligence has improved our predictive models and diagnostic capabilities. Social media is emerging as a tool to reach populations previously unengaged by health care. Despite these promising advances, disparities are increasingly being recognized in the creation, implementation, and use of these technologies. In this session, we will highlight disparities within telehealth and artificial intelligence/machine learning, but also outline evidence-based methods to promote equity within these disciplines. We will also discuss the role of social media in creating diverse communities for practitioners, advocates, and patients, and review how social media has facilitated outreach to vulnerable communities.

    Moderators

    Speaker Image for Jeremy Louissaint
    The University of Texas Southwestern Medical Center
    Speaker Image for Victor Chedid
    Mayo Clinic Minnesota
  • Thumbnail for CURRENT DISPARITIES IN TELEHEALTH: ARE WE WIDENING THE DIGITAL DIVIDE?
    Date
    May 6, 2023
    Society: AGA

    The use of technology has expanded rapidly in clinical care and research in gastroenterology. Telehealth has improved access to care and transformed the ability to monitor patients from the safety of their own homes. Artificial intelligence has improved our predictive models and diagnostic capabilities. Social media is emerging as a tool to reach populations previously unengaged by health care. Despite these promising advances, disparities are increasingly being recognized in the creation, implementation, and use of these technologies. In this session, we will highlight disparities within telehealth and artificial intelligence/machine learning, but also outline evidence-based methods to promote equity within these disciplines. We will also discuss the role of social media in creating diverse communities for practitioners, advocates, and patients, and review how social media has facilitated outreach to vulnerable communities.
  • Thumbnail for AGA Kristin and David Peura, MD, Lecture: Diagnosis and Management of Chronic Gastritis and Its Neoplastic Sequelae
    Date
    May 6, 2023
    Society: AGA

    Gastritis is frequently encountered by gastroenterologists in their evaluation of patients with foregut-related symptoms. There is an unmet need for GI clinicians to become familiar with the many types of gastritis given the several etiologies present, and the implications for treatment, prognosis, and surveillance. Gastric metaplasia, although uncommon in US populations, presents a quandary for practicing physicians given the general unfamiliarity with its classification, management and prognosis. Several novel endoscopic techniques have been proposed to improve the diagnosis of gastric preneoplastic lesions and help personalize and guide the most appropriate surveillance strategy. The purpose of this session is thus to familiarize clinicians with how to approach and manage the patient with gastritis and/or gastric atrophy/metaplasia with the aim of obtaining a definitive diagnosis, staging and grading the lesion, identifying the likely etiologic factor, and initiating appropriate treatment and surveillance.

    Moderators

    Speaker Image for Peter Malfertheiner
    University of Magdeburg
    Speaker Image for Robert Genta
    Miraca Life Sciences
  • Thumbnail for GASTRITIS, ATROPHY AND METAPLASIA: A PATHOLOGISTS PERPECTIVE
    Date
    May 6, 2023
    Society: AGA

    Gastritis is frequently encountered by gastroenterologists in their evaluation of patients with foregut-related symptoms. There is an unmet need for GI clinicians to become familiar with the many types of gastritis given the several etiologies present, and the implications for treatment, prognosis, and surveillance. Gastric metaplasia, although uncommon in US populations, presents a quandary for practicing physicians given the general unfamiliarity with its classification, management and prognosis. Several novel endoscopic techniques have been proposed to improve the diagnosis of gastric preneoplastic lesions and help personalize and guide the most appropriate surveillance strategy. The purpose of this session is thus to familiarize clinicians with how to approach and manage the patient with gastritis and/or gastric atrophy/metaplasia with the aim of obtaining a definitive diagnosis, staging and grading the lesion, identifying the likely etiologic factor, and initiating appropriate treatment and surveillance.

    Presenter

    Speaker Image for Robert Genta
    Miraca Life Sciences
  • Thumbnail for AGA Epigenetic Mechanisms Driving GI Cancer
    Date
    May 6, 2023
    Society: AGA

    The epigenome is the heritable portion of the genome that is mediated by chemical modification of DNA (methylation) or nuclear proteins (histones, transcription factors) without changing the DNA sequence. This session will focus on what defines the epigenome, technologies that allow us to track the epigenome and how novel cancer therapies are developed that target regulators of the epigenome.

    Moderators

    Speaker Image for Eileen Carpenter
    University of Michigan
    Speaker Image for Ajay Goel
    Beckman Research Institute, City of Hope Comprehensive Cancer Center
  • Thumbnail for TARGETING THE EPIGENOME IN PANCREATIC CANCER
    Date
    May 6, 2023
    Society: AGA

    The epigenome is the heritable portion of the genome that is mediated by chemical modification of DNA (methylation) or nuclear proteins (histones, transcription factors) without changing the DNA sequence. This session will focus on what defines the epigenome, technologies that allow us to track the epigenome and how novel cancer therapies are developed that target regulators of the epigenome.
  • Thumbnail for AGA The Public Health Crisis in Nutrition: Enteral and Parenteral
    Date
    May 6, 2023
    Society: AGA

    There have been numerous times in the past few years wherein natural or man-made disasters have impacted the production and supply chain of key constituents of both enteral and parenteral nutrition products. These have impacted individuals on total parenteral nutrition (TPN) and on tube feeds or children/infants that are exclusively fed formula or suffer from metabolic or allergic disorders that necessitate them being on certain medical foods/specialty formula. As a community gastroenterolgists have been asked to step up in these situations to advocate for and construct disaster management plans. Through this session we would like to raise awareness for these general issues and provide state of the art guidance for these specific issues pertinent to daily clinical practice. LIVE STREAM SESSION

    Moderators

    Speaker Image for Jenifer Lightdale
    UMass Memorial Medical Center University Campus
    Speaker Image for Russell Merritt
    Children's Hospital Los Angeles
  • Thumbnail for HOW TO REJIG YOUR TPN WHEN THE DELIVERY IS LATE
    Date
    May 6, 2023
    Society: AGA

    There have been numerous times in the past few years wherein natural or man-made disasters have impacted the production and supply chain of key constituents of both enteral and parenteral nutrition products. These have impacted individuals on total parenteral nutrition (TPN) and on tube feeds or children/infants that are exclusively fed formula or suffer from metabolic or allergic disorders that necessitate them being on certain medical foods/specialty formula. As a community gastroenterolgists have been asked to step up in these situations to advocate for and construct disaster management plans. Through this session we would like to raise awareness for these general issues and provide state of the art guidance for these specific issues pertinent to daily clinical practice. LIVE STREAM SESSION

    Presenter

  • Thumbnail for AGA Diagnostic Controversies in Chronic Pancreatitis
    Date
    May 6, 2023
    Society: AGA

    Moderators

    Speaker Image for Allison Yang
    Weill Cornell Medicine/New York Presbyterian
    Speaker Image for Michele Lewis
    Mayo Clinic
    Speaker Image for Anna Phillips
    University of Pittsburgh Medical Center
  • Thumbnail for HISTORY AND RISK ASSESSMENT
    Date
    May 6, 2023
    Society: AGA

    Presenter

  • Thumbnail for DDW Multimodal GERD Management: Gastroenterologist and Surgeons Optimizing Treatment Together
    Date
    May 6, 2023
    Society: DDW

    LIVE STREAM SESSION

    Moderators

    Speaker Image for Yalini Vigneswaran
    University of Chicago
    Speaker Image for Michael Smith
    Icahn School of Medicine at Mount Sinai Department of Medicine
    Speaker Image for Prashant Kedia
    Methodist Dallas Medical Center
  • Thumbnail for AGA Pediatric Gastroenterology
    Date
    May 6, 2023
    Society: AGA

    Moderators

    Speaker Image for Robert Shulman
    Texas Children's Hospital, Baylor College of Medicine
    Speaker Image for Mirna Chehade
    Mount Sinai School of Medicine